NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india) arrow 11674.00 -149.30 -1.26%
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Sorin (BIT: SRN)

 
SRN Technical Analysis
4
As on 16th Oct 2015 SRN Share Price closed @ 2.87 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 2.49 & Buy for SHORT-TERM with Stoploss of 2.73 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

SRN Share Price

Open 2.85 Change Price %
High 2.88 1 Day 0.00 0.00
Low 2.84 1 Week 0.00 0.00
Close 2.87 1 Month 0.00 0.00
Volume 4849591 1 Year 0.00 0.00
52 Week High 5.89 | 52 Week Low 3.32
 
BIT Italy Most Active Stocks
RN 0.04 0.00%
PMI 0.36 0.00%
TIT 0.75 1.35%
ISP 2.89 0.00%
F 6.94 -2.12%
TIS 0.04 0.00%
SPM 3.80 5.26%
ENEL 5.39 1.32%
TITR 0.62 1.64%
CRG 0.21 0.00%
 
BIT Italy Top Gainers Stocks
PGR 300.00 20.00%
PGR 300.00 20.00%
PGR 300.00 20.00%
PGR 300.00 20.00%
AE 0.50 8.70%
AE 0.50 8.70%
DIS 0.28 7.69%
DIS 0.28 7.69%
DIS 0.28 7.69%
DIS 0.28 7.69%
 
BIT Italy Top Losers Stocks
ME 0.09 -10.00%
ME 0.09 -10.00%
FTL 3.65 -7.36%
TBS 1.64 -6.82%
STEF 0.19 -5.00%
POPR 0.59 -4.84%
BIM 0.65 -4.41%
BIM 0.65 -4.41%
ZUCR 0.24 -4.00%
S24 1.70 -3.95%
 
 
SRN
Daily Charts
SRN
Intraday Charts
Whats New @
Bazaartrend
SRN
Free Analysis
 
SRN Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE2.91
RESISTANCE2.89
SUPPORT2.85
SUPPORT2.83
SUPPORT0.00
SUPPORT0.00
 
SRN Target for Month June
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
SRN Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
SRN Target for Year 2019
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
SRN Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.sorin.com
 
SRN Address
SRN
Via Benigno Crespi, 17
Milan, MI 20159
Italy
Phone: 39 02 69 96 97 11
 
SRN Latest News
 
Your Comments and Response on Sorin
 
SRN Business Profile
Sorin S.p.A. develops, produces, and distributes medical devices for cardiac surgery and for the treatment of cardiac rhythm dysfunctions. It offers disposable biomedical devices and systems, including heart-lung machines; cardiopulmonary systems, such as oxygenators and custom packs; autotransfusion systems and disposables; perfusion tubing systems; cannulae; and endoscopic vessel harvesting systems for extracorporeal circulation during surgery. The company also provides mechanical heart valves, tissue heart valves, self-anchoring tissue heart valves, and annuloplasty rings to replace or repair dysfunctional heart valves or treat congenital diseases. In addition, it offers implantable devices, monitoring systems, and accessories to treat cardiac rhythm dysfunctions that comprise pacemakers, implantable defibrillators, systems to treat heart failure (CRT-D), programmers, electrodes, electrophysiology leads, and Holter monitors; and disposable medical devices for urology, urodynamics, heart surgery, and haemodialysis. The company sells its products worldwide primarily under the Sorin Biomedica, Dideco, Stöckert, Cobe Cardiovascular, Ela Medical, and Carbomedics brand names. Sorin S.p.A. was founded in 2004 and is headquartered in Milan, Italy.
 
© 2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service